NCT03841448

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Study was terminated early having identified clinically meaningful magnitude of proteinuria reduction due to cemdisiran (study goal). Participants completed DBT period\&were in OLE period. Sponsor had no concerns with safety\&integrity of participants.